Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NCF1 | P14598 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.64 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.59 |
| ▸ | ACHE | P22303 | 2/20 | 0.58 |
| ▸ | BACE1 | P56817 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | HPGD | P15428 | 3/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | CASP1 | P29466 | 2/20 | 0.53 |
| ▸ | CASP7 | P55210 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.52 |
| ▸ | GNG2 | P59768 | 2/20 | 0.50 |
| ▸ | GNB1 | P62873 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29557788 | 1.00 | NCF1 (1.00) | NCF1CYP1A2NR4A2ACHEBACE1 | |
| Hydrochloric Acid SCHEMBL4754644 | 0.98 | NCF1 (0.96) | NCF1CYP1A2NR4A2ACHEBACE1 | |
| Iodide SCHEMBL27942629 | 0.98 | NCF1 (0.96) | NCF1CYP1A2NR4A2ACHEBACE1 | |
| Hydrochloric Acid SCHEMBL29209114 | 0.98 | NCF1 (0.96) | NCF1CYP1A2NR4A2ACHEBACE1 | |
| Hydrochloric Acid SCHEMBL27703457 | 0.98 | NCF1 (0.96) | NCF1CYP1A2NR4A2ACHEBACE1 | |
| Iodide SCHEMBL27879134 | 0.96 | NCF1 (0.92) | NCF1CYP1A2NR4A2ACHEBACE1 | |
| Decane SCHEMBL27942633 | 0.88 | NCF1 (0.77) | NCF1CYP1A2NR4A2ACHEBACE1 | |
| Quinoline SCHEMBL28231960 | 0.87 | NCF1 (0.75) | NCF1CYP1A2NR4A2ACHEBACE1 | |
| SCHEMBL8209615 | 0.85 | NCF1 (0.73) | NCF1CYP1A2NR4A2ACHEBACE1 | |
| SCHEMBL5998804 | 0.84 | NCF1 (0.71) | NCF1CYP1A2NR4A2ACHEBACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 630 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250177373-A1 | COMPOSITIONS AND METHODS FOR TARGETING A VIRAL INFECTION | THE CHILDEREN'S MEDICAL CENTER CORPORATION (US) | 2025-06-05 | — | — | US | claimed |
| CN-118995223-A | High performance selective etching solution for silicon in silicon germanium/silicon laminate | 湖北兴福电子材料股份有限公司 | 2024-11-22 | — | — | CN | claimed |
| EP-4399202-A1 | SUBSTITUTED QUINOLINES AS IMPROVED NF-KB-INDUCING KINASE (NIK) INHIBITORS | Yukin Therapeutics (FR) | 2024-07-17 | — | — | EP | claimed |
| CN-117417747-A | Silicon selective etching solution relative to silicon germanium | 湖北兴福电子材料股份有限公司 | 2024-01-19 | — | — | CN | claimed |
| EP-4302833-A2 | COMPOSITIONS FOR MODULATING PD-1 SIGNAL TRANSDUCTION | Augusta University Research Institute, Inc. (US) | 2024-01-10 | — | — | EP | claimed |
| WO-2023072962-A1 | SUBSTITUTED QUINOLINES AS IMPROVED NF-KB-INDUCING KINASE (NIK) INHIBITORS | Yukin Therapeutics (FR) | 2023-05-04 | — | — | WO | claimed |
| EP-2586893-B1 | COPPER PLATING BATH AND CORRESPONDING METHOD | ROHM & HAAS ELECT MAT (US) | 2022-09-21 | — | — | EP | claimed |
| CN-111018777-B | Preparation method of dequalinium chloride | 武汉智顿科技发展有限公司 | 2021-02-12 | — | — | CN | claimed |
| CN-110963967-B | Preparation method of 2-methyl-4-aminoquinoline | 武汉智顿科技发展有限公司 | 2021-02-12 | — | — | CN | claimed |
| CN-111018777-A | Preparation method of dequalinium chloride | 武汉智顿科技发展有限公司 | 2020-04-17 | — | — | CN | claimed |
| CN-1252707-A | Use of unsaturated aldehydes in dying fibers containing keratin | HENKEL KGAA (DE) | 2000-05-10 | — | — | CN | claimed |
| EP-0506207-B1 | Pharmaceutical vehicles for reducing transdermal flux | ACCESS PHARMA INC (US) | 1999-11-17 | — | — | EP | claimed |
| WO-1998027815-A1 | SUBSTITUTED AMINOQUINOLINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | MERCK & CO., INC. (US) | 1998-07-02 | — | — | WO | claimed |
| US-5657064-A | Recording sheets containing pyrrole, pyrrolidine, pyridine, piperidine, homopiperidine, quinoline, isoquinoline, quinuclidine, indole, and indazole compounds | XEROX CORPORATION (US) | 1997-08-12 | — | — | US | claimed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | claimed |
| EP-0673782-A2 | Recording sheets containing pyrrole, pyrrolidine, pyridine, piperidine, homopiperidine, quinoline, isoquinoline, quinuclidine, indole, and indazole compounds | XEROX CORPORATION (US) | 1995-09-27 | — | — | EP | claimed |
| EP-0151203-B1 | ANTI-PLAQUE DENTURE CLEANSING TABLET | Richardson GmbH (DE) | 1989-08-16 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250177373-A1 | COMPOSITIONS AND METHODS FOR TARGETING A VIRAL INFECTION | HAVCR2, CD4, MAVS | NCF1 1375/4885CYP1A2 4771/4885NR4A2 2844/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.